BACKGROUND: have beneficial effects on the immune system and can fight against cancer by inhibiting the growth of tumor cells, preventing angiogenesis, and promoting immune activation. OBJECTIVE: on the growth of colon and breast cancer cells, to understand the underlying mechanisms of action. RESULTS: and are characterized as common antigenic determinants, inducing a cross-immune response. In addition, molecules secreted by the parasite are used recombinantly in immunotherapy against cancer for their ability to generate a reliable and long-lasting immune response. CONCLUSION: , this study provides valuable insights for developing novel therapeutic strategies to combat colon and breast cancer.
No takes yet. Share an insight, caveat, or question.
Sadr et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: